Health-Informant.com :: http://www.health-informant.com

Recent Articles
Important New Data Presented Validating The Potential Of New Toothpaste Technology Added: 09/08/2007 Type: Summary [ Not Rated Yet ]
New study presented at the 54th European Organization for Caries Research (ORCA) Congress, July 2007 confirms data also presented at the International Association of Dental Research (IADR), March 2007 Read Full Article \| Printer Friendly Version
VOCA Unveils Chiropractic Malpractice Postage Stamp Approved by US Postal Service Added: 09/07/2007 Type: Summary [ Not Rated Yet ]
Victims of Chiropractic Abuse releases a stamp about efforts to raise awareness of the risks of chiropractic treatment. Read Full Article \| Printer Friendly Version
Theravitae Announces Hawaiian Doctor is One of The First Patients in the World Added: 09/04/2007 Type: Summary [ Not Rated Yet ]
Theravitae, an international stem cell company says a doctor from Hawaii is believed to be one of the first patients in the world to receive not one, but two different stem cell treatments. His first treatment injected his stem cells directly into the heart muscle to treat his congestive heart failure and now he is having more stem cells injected into his coronary arteries by catheter to treat his coronary artery disease Read Full Article \| Printer Friendly Version
Sub Prime Crisis is Only the Tip of the Iceberg: Critical Illness Causes 50% of Home Foreclosures Added: 09/03/2007 Type: Summary [ Not Rated Yet ]
Twenty-five people suffer a critical illness every four minutes, that's 1 in 2.5 adults -- which leads to stress, misery and financial hardship for other family members. Sam Harris reveals some startling statistics and thinks many North Americans need to change their priorities. Read Full Article \| Printer Friendly Version
Biomarck Pharmaceuticals Ltd. Raises $4 Million Added: 09/01/2007 Type: Summary [ Not Rated Yet ]
BioMarck Pharmaceuticals, a Research Triangle Park drug development company, raised $ 4 million through private placement financing. The financing together with prior National Institutes of Health grants is intended to provide sufficient funds to complete a Phase II, proof of concept clinical study, says Allen F. Gant, Chairman and CEO. Read Full Article \| Printer Friendly Version